bioRxivMicrobiology
Influenza C incidence and herd immunity in Lancaster, UK, in the winter of 2014-2015
K. V. Atkinson, L. A. Bishop, G. Rhodes, N. Salez, N. R. McEwan, M. J. Hegarty, J. Robey, N. Harding, S. Wetherell, R. M. M. Lauder, R. W. W. Pickup, M. Wilkinson, D. Gatherer
Abstract
Influenza C is not included in the annual seasonal influenza vaccine, and has historically been regarded as a minor respiratory pathogen. However, recent work has highlighted its potential role as a cause of pneumonia in infants. We performed nasopharyngeal or nasal swabbing and/or serum sampling (n=148) in Lancaster, UK, over the winter of 2014-2015. Using enzyme-linked immunosorbent assay (ELISA), we estimated a seropositivity of 77%. By contrast, only 2 individuals, both asymptomatic adults, were influenza C-positive by polymerase chain reaction (PCR). Deep sequencing of nasopharyngeal samples produced partial sequences for 4 genome segments in one of these patients. Bayesian phylogenetic analysis demonstrated that the influenza C genome from this individual is evolutionarily distant to those sampled in recent years and represents a novel genome constellation, indicating that it is a product of a decades-old reassortment event. Although we find no evidence that influenza C was a significant respiratory pathogen during the winter of 2014-2015 in Lancaster, we confirm previous observations of seropositivity in the majority of the population. We calculate that this level of herd immunity would be sufficient to suppress epidemics of influenza C and restricts the virus to sporadic endemic spread.
- organism: human
- assay: metagenomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterising the epidemic spread of Influenza A/H3N2 within a city through phylogenetics
N. F. Müller, D. Wüthrich, … T. Stadler·bioRxiv·Apr 27, 2020
- Serologic evidence of seasonal influenza A and B viruses in HIV patients on combined antiretroviral therapy in Lagos, Nigeria
A. A. Anjorin, B. A. Adepoju·bioRxiv·Feb 18, 2019
- Distinct Longitudinal Antibody Responses Following Primary Influenza Infection or Vaccination in Infants: A Prospective Birth Cohort Study
Devyani Joshi, Sanjeev Kumar, … Jens Wrammert·bioRxiv·Sep 30, 2026
- Emergence of an Antigenically Drifted and Reassorted Influenza B Virus at the end of the 2024-25 Influenza Season
Elgin Henry Akin, David A. Villafuerte, … Andrew S Pekosz·mBioPeer-reviewed·Jun 22, 2026
- Integrating Patient And Whole Genome Sequencing Data To Provide Insights Into The Epidemiology Of Seasonal Influenza A(H3N2) Viruses
E. J. Goldstein, W. T. Harvey, … R. N. Gunson·Microbial GenomicsPeer-reviewed·Jan 1, 2018
- Effect of Live Attenuated Influenza Vaccine on Pneumococcal Carriage
J. Rylance, W. A. de Steenhuijsen Piters, … D. M. Ferreira·bioRxiv·Jun 14, 2018